ONO-6818 Cortech/Ono

Current Opinion in Investigational Drugs

Volumn 3, Issue 8, 2002, Pages 1161-1164

  Trifilieff, Alexandre ^a  

^a Novartis Institutes for Biomedical Research   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CP 955; LEUKOCYTE ELASTASE; LEUKOCYTE ELASTASE INHIBITOR; MIDESTEINE; N [1 (1,3 BENZODIOXOL 5 YL)BUTYL] 3,3 DIETHYL 2 [4 [(4 METHYL 1 PIPERAZINYL)CARBONYL]PHENOXY] 4 OXO 1 AZETIDINECARBOXAMIDE; N [2 (5 TERT BUTYL 1,3,4 OXADIAZOL 2 YL) 1 METHYLETHYL 2 OXOETHYL] 2 (5 AMINO 6 OXO 2 PHENYL 6H PYRIMIDIN 1 YL)ACETAMIDE; ONO 6818; PYRIMIDINONE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CYSTIC FIBROSIS; DISEASE MODEL; DOSE RESPONSE; DRUG ACTIVITY; DRUG BINDING; DRUG BIOAVAILABILITY; DRUG METABOLISM; DRUG POTENCY; DRUG SAFETY; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENTERITIS; FOOD DRUG INTERACTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; NONHUMAN; REVIEW; RHEUMATOID ARTHRITIS; SIDE EFFECT; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CLINICAL TRIALS, PHASE I; ENZYME INHIBITORS; HUMANS; LEUKOCYTE ELASTASE; OXADIAZOLES; PYRIMIDINONES;

EID: 0036707266     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. 174095 Cortech and ONO collaborate in oral elastase inhibitor development. Cortech Press Release 1995 March 13 Cortech and ONO announce their collaboration in the development of an oral elastase inhibitor. ONO will fund Cortech's research of potential orally bioavailable human elastase inhibitors.
2. 230053 MR889, a neutrophil elastase inhibitor, in patients with chronic obstructive pulmonary disease: A double-bind, randomized, placebo-controlled clinical trial. Luisetti M, Sturani C, Sella D, Madonini E, Galavotti V, Bruno G, Peona V, Kucich U, Dagnino G, Rosenbloom J, Starcher B, Grassi C Eur Respir 1996 9 7 1482-1486
3. 247240 Ono amend collaboration with Cortech. Scrip 1997 2231 10
4. 296641 Cortech seeks to establish new company based on its protease inhibitor technology. Cortech Inc Press Release 1998 September 01
5. 317583 Cortech makes announcement. Cortech Inc Press Release 1999 March 08
6. 366431 Ono's new drugs R&D pipeline. Pharma Jpn 1999 1675 16
7. 368565 Drug development pipeline: ONO-6818, ONO-8815. Ono Pharmaceutical Co Ltd Company Communication 2000 May 30
8. 381286 Structural and inflammatory changes in COPD: A comparison with asthma. Jeffery PK Thorax 1998 53 2 129-136
9. 391542 Ono: Aims at overseas business development through tie-ups. Pharma Jpn 2000 1723 13
10. 404465 Development of orally active nonpeptidic inhibitors of human neutrophil elastase. Ohmoto K, Yamamoto T, Okuma M, Horiuchi T, Imanishi H, Odagaki Y, Kawabata K, Sekioka T, Hirota Y, Matsuoka S, Nakai H et al J Med Chem 2001 44 8 1268-1285
11. 195 hydroxyl group in the active site of elastase.
12. 422782 Industry - Healthcare (pharmaceuticals): Wait-&-see stance retained; Valuations more attractive. Mita M Morgan Stanley Dean Witter 2001 September 11
13. 423688 In vivo effects of ONO-6818, an orally active neutrophil elastase inhibitor. Sekikoa T, Kitagawa K, Nakao S, Hagio T, Tanaka K, Kawabata K, Obata T Inflamm Res 2001 50 Suppl 3 W19/03
14. 430508 Effect of a neutrophil elastase inhibitor on airway goblet cell secretion in sensitized guinea pigs. Nakata J, Tamaoki J, Kondo M, Nagai A Ann Congr Eur Resp Soc 2001 September 22-26 Abs 1687
15. 446138 Dedicated to man's fight against disease and pain. Ono Pharmaceutical Co Ltd Annual Report 2001 June 28
16. 448417 Design and synthesis of new orally active ihibitors of human neutrophil elastase. Ohmoto K, Okuma M, Yamamoto T, Kijima H, Sekioka T, Kitagawa K, Yamamoto S, Tanaka K, Kawabata K, Sakata A, Imawaka H et al Bioorg Med Chem 2001 9 5 1307-1323
17. 448419 Improved synthesis of a new nonpeptidic inhibitor of human neutrophil elastase. Ohmoto K, Yamamoto T, Horiuchi T, Kojima T, Hachiya K, Hashimoto S, Kawamura M, Nakai H, Toda M Synlett 2001 2 299-301
18. 448420 Production and pharmacologic modulation of the granulocyte-associated allergic responses to ovalbumin in murine skin models induced by injecting ovalbumin-specific Th1 or Th2 cells. Terui T, Sano K, Okada M, Shirota H, Honda M, Ozawa M, Hirasawa N, Tamura G, Tagami H J Invest Dermatol 2001 117 2 236-243
19. 453940 Pharmacological profile of a novel orally active neutrophil elastase inhibitor, ONO-6818. Seikioka T, Hirota Y, Nakao S, Sato W, Omoto K, Tanaka T, Kawabata K, Obata T Am J Respir Crit Care Med 2001 163 A597
20. 456596 Ono Pharmaceutical. Mizuno Y, Miyauchi K Daiwa Institute Research Ltd 2002 May 21
21. 456597 Healthcare: Slowing momentum. Mita M Morgan Stanley Dean Witter 2002 June 18
22. 456761 Annual flash report (unaudited): Year ended March 31 2002. Ono Pharmaceutical Co Ltd Company Publication 2002 May 17